PreveCeutical Medical Inc. (PRVCF)
OTCMKTS · Delayed Price · Currency is USD
0.0270
+0.0017 (6.51%)
Aug 18, 2025, 2:30 PM EDT
PreveCeutical Medical Market Cap
PreveCeutical Medical has a market cap or net worth of $12.40 million as of August 18, 2025. Its market cap has increased by 58.51% in one year.
Market Cap
12.40M
Enterprise Value
15.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since July 14, 2017, PreveCeutical Medical's market cap has increased from 4.79M to 12.40M, an increase of 159.01%. That is a compound annual growth rate of 12.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 12.40M | 31.76% |
| Dec 31, 2024 | 9.41M | -7.12% |
| Dec 29, 2023 | 10.13M | 2.48% |
| Dec 30, 2022 | 9.89M | -1.01% |
| Dec 29, 2021 | 9.99M | -13.80% |
| Dec 31, 2020 | 11.59M | 152.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.94M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |